Atavistik Bio Announces Research Collaboration with Pfizer
Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two undisclosed, Pfizer-designated...
Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two undisclosed, Pfizer-designated...
TRIANA will receive an upfront payment of $49 million, and is eligible to receive future milestone payments and royalties LEXINGTON,...